<video id="95jvn"><strike id="95jvn"><th id="95jvn"></th></strike></video>
<track id="95jvn"><form id="95jvn"></form></track>
<span id="95jvn"><th id="95jvn"><progress id="95jvn"></progress></th></span>
<ruby id="95jvn"><thead id="95jvn"></thead></ruby>

          <big id="95jvn"><span id="95jvn"></span></big>

          <track id="95jvn"></track>
          來寶網Logo

          熱門詞:生物顯微鏡 水質分析儀 微波消解 熒光定量PCR 電化學工作站 生物安全柜

          AED
          現在位置首頁>實驗室服務>實驗室服務>抗體定制>Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802
          Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802
          Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802
          • Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802

          Anti- Dxd (Exatecan derivative for ADC) antibody, mAbYKZP1802

          產品報價:39800元

          更新時間:2022/4/14 14:38:38

          地:上海

          牌:友科生物

          號:YKZP1802

          廠商性質:

          公司名稱: 上海友科生物科技有限公司

          產品關鍵詞: 抗體藥物定制開發   多抗制備   多克隆抗體定制   抗體定制   多克隆抗體制備  

          126
          訪問人數
          0
          累計評論


          熊女士 : (17706252173) (021-58955621)

          (聯系我時,請說明是在來寶網上看到的,謝謝?。?/b>


          Anti- Dxd (Exatecan derivative for ADC) antibody, mAb YKZP1802

          Dxd 鼠單抗

          編號:YKZP1802

          Background
          Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a). Dxd is cytotoxic to human cancer cell lines of KPL-4, NCI-N87, SK-BR-3, and MDA-MB-468 with IC50s of 1.43 nM-4.07 nM, but the control IgG-ADC (Dxd is the payload) shows no inhibition on the four cell lines (with HER2 expression). DS-8201a (Dxd is the payload) displays significant suppression on the HER2-positive KPL-4, NCI-N87, and SK-BR-3 cell lines, with IC50 values of 26.8, 25.4, and 6.7 ng/mL, respectively, but with no such inhibition on MDA-MB-468 (IC50, >10,000 ng/mL).

          Anti- Dxd (Exatecan derivative for ADC) antibody, mAb YKZP1802

          Monomethyl auristatin E (MMAE; SGD-1010) 是海兔毒素10的合成衍生物,通過抑制微管蛋白聚合而起到有效的有絲分裂抑制作用。MMAE廣泛用作細胞毒性成分制作抗體-藥物偶聯物 (ADCs) 以治療癌癥。

          Dxd (Exatecan derivative for ADC) is a potent inhibitor of DNA topoisomerase I (IC50: 0.31 μM). It is used as a conjugated drug of HER2-targeting ADC.

          #ADC-Ab0001 mouse monoclonal antibody can recognize Dxd and Dxd structurally similar molecules

          Concentration:

          1 mg/ml. Protein was determined by OD280 absorbance.

          Physical State:Liquid

          Reactivity:

          Dxd and Dxd structurally similar molecules

          Storage Condition:Store at -20 °C. Stable for 12 months from date of receipt.

          Anti-MMAF (Monomethyl Auristain F) antibody, mAb YKZP1802

          MMAF鼠單抗 

          Background

          Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody.


           Anti-MMAF (Monomethyl Auristain F) antibody, mAb

          MMAF (Monomethylauristatin F) hydrochloride 是一種有效的微管蛋白聚合 (tubulin polymerization抑制劑,用作抗腫瘤藥物。MMAF hydrochloride 廣泛用作抗體偶聯藥物 (ADCs) 的細胞毒性成分,如 Vorsetuzumab mafodotin  SGN-CD19A。

           




          上海友科生物科技有限公司

          | 第4

          手機:17706252173

          聯系人:熊女士

          電話:021-58955621

          傳真:

          QQ:2969807024

          (聯系我時,請說明是在來寶網上看到的,謝謝?。?/strong>